I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 12 studies | 36% ± 17% | |
| GABAergic neuron | 4 studies | 20% ± 5% | |
| neuron | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 12 studies | 36% ± 17% | |
| GABAergic neuron | 4 studies | 20% ± 5% | |
| neuron | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 3086.11 | 2641 / 2642 | 99% | 83.76 | 699 / 705 |
| kidney | 76% | 643.92 | 68 / 89 | 92% | 16.00 | 829 / 901 |
| adrenal gland | 97% | 657.28 | 251 / 258 | 60% | 5.86 | 139 / 230 |
| spleen | 100% | 2810.99 | 241 / 241 | 0% | 0 | 0 / 0 |
| intestine | 71% | 871.11 | 689 / 966 | 24% | 1.48 | 127 / 527 |
| muscle | 94% | 1048.12 | 756 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 87% | 1118.29 | 1161 / 1335 | 0% | 0 | 0 / 0 |
| breast | 81% | 494.08 | 371 / 459 | 6% | 0.28 | 62 / 1118 |
| adipose | 77% | 473.83 | 928 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 62% | 292.12 | 105 / 170 | 14% | 2.25 | 66 / 459 |
| stomach | 46% | 222.23 | 164 / 359 | 26% | 1.53 | 74 / 286 |
| thymus | 42% | 191.89 | 274 / 653 | 29% | 3.31 | 174 / 605 |
| lung | 58% | 361.51 | 336 / 578 | 10% | 0.72 | 116 / 1155 |
| eye | 0% | 0 | 0 / 0 | 59% | 4.50 | 47 / 80 |
| pancreas | 26% | 92.18 | 84 / 328 | 33% | 1.99 | 58 / 178 |
| heart | 52% | 230.21 | 448 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 34% | 154.91 | 489 / 1445 | 4% | 0.20 | 7 / 183 |
| skin | 23% | 91.90 | 422 / 1809 | 11% | 1.13 | 50 / 472 |
| bladder | 19% | 114.24 | 4 / 21 | 10% | 0.58 | 52 / 504 |
| prostate | 21% | 87.55 | 51 / 245 | 6% | 0.26 | 31 / 502 |
| liver | 4% | 17.31 | 8 / 226 | 19% | 1.06 | 76 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 1.84 | 10 / 45 |
| ovary | 16% | 80.86 | 29 / 180 | 3% | 0.22 | 14 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.12 | 1 / 29 |
| peripheral blood | 0% | 0.30 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0008146 | Molecular function | sulfotransferase activity |
| Gene name | WSCD1 |
| Protein name | Sialate:O-sulfotransferase 1 (WSC domain-containing protein 1) WSC domain containing 1 |
| Synonyms | KIAA0523 |
| Description | FUNCTION: Sialate:O-sulfotransferase which catalyzes 8-O-sulfation at the Sia-glycan level using 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a donor, forming 8-O-sulfated Sia (Sia8S)-glycans. Displays selectivity toward glycolipids such as GM1 gangliosides. . FUNCTION: Sialate:O-sulfotransferase which catalyzes 8-O-sulfation at the Sia-glycan level using 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a donor, forming 8-O-sulfated Sia (Sia8S)-glycans. . |
| Accessions | I3L3G4 ENST00000571494.1 A0A1B0GXC0 ENST00000574946.5 Q658N2 ENST00000573634.5 I3L0U0 ENST00000576233.1 I3L127 I3L3E6 ENST00000317744.10 ENST00000571973.1 ENST00000574232.5 ENST00000576947.1 |
